Cargando…
Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846886/ https://www.ncbi.nlm.nih.gov/pubmed/33529740 http://dx.doi.org/10.1016/j.annonc.2021.01.066 |
| _version_ | 1783644826761166848 |
|---|---|
| author | Barrière, J. Gal, J. Hoch, B. Cassuto, O. Leysalle, A. Chamorey, E. Borchiellini, D. |
| author_facet | Barrière, J. Gal, J. Hoch, B. Cassuto, O. Leysalle, A. Chamorey, E. Borchiellini, D. |
| author_sort | Barrière, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7846886 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78468862021-02-01 Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey Barrière, J. Gal, J. Hoch, B. Cassuto, O. Leysalle, A. Chamorey, E. Borchiellini, D. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2021-05 2021-01-30 /pmc/articles/PMC7846886/ /pubmed/33529740 http://dx.doi.org/10.1016/j.annonc.2021.01.066 Text en © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Barrière, J. Gal, J. Hoch, B. Cassuto, O. Leysalle, A. Chamorey, E. Borchiellini, D. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title | Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title_full | Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title_fullStr | Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title_full_unstemmed | Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title_short | Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey |
| title_sort | acceptance of sars-cov-2 vaccination among french patients with cancer: a cross-sectional survey |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846886/ https://www.ncbi.nlm.nih.gov/pubmed/33529740 http://dx.doi.org/10.1016/j.annonc.2021.01.066 |
| work_keys_str_mv | AT barrierej acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT galj acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT hochb acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT cassutoo acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT leysallea acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT chamoreye acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey AT borchiellinid acceptanceofsarscov2vaccinationamongfrenchpatientswithcanceracrosssectionalsurvey |